Patent US4759368A successfully refreshed from Google Patents.
US4759368A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Transcutaneous nerve stimulator
Assignee: MEDICAL DESIGNS Inc A CORP OF DE
•
Filing: 1986-12-02
•
Granted: 1988-07-26
•
Expires: 2006-12-02
Abstract
Abstract A transcutaneous nerve stimulating device is provided having a plurality of operating modes, namely burst, normal (single amplitude/single pulse width), rate modulation, amplitude modulation and strength-duration/rate modulation. In the lattermost mode, the rate modulation control circuitry acts independently of the inter-related amplitude and pulse width modulations to result in a means of nerve stimulation obviating the phenomenon of accommodation.
Inventors
- 👤 John B. Spanton
- 👤 Gregory A. Todd
- 👤 John P. Landino
- 👤 Terry A. Todd
- 👤 Richard J. Fisher, Jr.
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 06:07
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/18; A61N1/32; A61N1/36; A61N1/36014; A61N1/36021
Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
132 words
A transcutaneous nerve stimulating device which eliminates the phenomenon of accommodation, comprising a pulse generator means for generating a plurality of pulses, interconnected amplitude, pulse width, and rate modulation control means, which cause the amplitude, pulse width and rate of the generated pulse to vary in a prescribed manner, said amplitude control means interacting with said pulse width control means such that a change in the pulse amplitude will effect an inverse change in the pulse width, with pulse width decreasing when pulse amplitude increases and with pulse width increasing when pulse amplitude decreases, said rate modulation control means acting independently of the relationship between said amplitude control means and pulse width control means to modulate the rate of the pulse generated, and means for carrying said pulses to tissue engaging electrodes.
Claim 2
Dependent Claim
132 words
A transcutaneous nerve stimulating device which eliminates the phenomenon of accommodation, comprising a pulse generator means for generating a plurality of pulses, interconnected amplitude, pulse width, and rate modulation control means, which cause the amplitude, pulse width and rate of the generated pulse to vary in a prescribed manner, said amplitude control means interacting with said pulse width control means such that a change in the pulse amplitude will effect an inverse change in the pulse width, with pulse width decreasing when pulse amplitude increases and with pulse width increasing when pulse amplitude decreases, said rate modulation control means acting independently of the relationship between said amplitude control means and pulse width control means to modulate the rate of the pulse generated, and means for carrying said pulses to tissue engaging electrodes.
Claim 3
Dependent Claim
31 words
A device according to claim 1 wherein said generated pulse is associated with a current flow which is allowed to bias Germanium diodes as part of the circuitry of said device.
Claim 4
Dependent Claim
18 words
A device according to claim 1 wherein said amplitude, pulse width and rate control means are electrically connected.
Claim 5
Dependent Claim
53 words
A device according to claim 1 wherein said prescribed manner first includes the decreasing of the rate followed by its increase back to the initial rate, and secondly the mutual interaction between the amplitude control means and the pulse width control means such that the pulse width is responsive to changes in amplitude.
Claim 6
Dependent Claim
12 words
A device according to claim 4 wherein said rate decreases by 50%.
Claim 7
Dependent Claim
46 words
A device according to claim 4 wherein said mutual interaction between said amplitude control means and said pulse width control means causes the pulse width to increase by 40% responsive to a decrease in the amplitude of 25%, followed by their return to their initial values.
Claim 8
Dependent Claim
33 words
A device according to claim 6 wherein said mutual interaction results in specific amplitude and pulse width values which if plotted would the approximate A-gamma-motor curve strength-duration associated with the nerve being stimulated.
Claim 9
Dependent Claim
26 words
A device according to claim 7 wherein said pulse width increases in response to a decrease in amplitude until said pulse width reaches the A-delta-pain line.
Claim 10
Dependent Claim
44 words
A device according to claim 4 wherein said prescribed manner has a modulation cycle of six seconds, said modulation cycle being the time of the rate modulation as well as the mutual interaction between the pulse width control means and the amplitude control means.
Claim 11
Dependent Claim
37 words
A device according to claim 1 which includes means for additional modes of operation having pulses generated in other than said prescribed manner, said additional modes including rate modulation, amplitude modulation, single amplitude/single pulse width and burst.
Claim 12
Dependent Claim
17 words
A device according to claim 1 wherein the prescribed manner includes decreasing of the rate by 50%.
Claim 13
Dependent Claim
50 words
A device according to claim 11 wherein said prescribed manner includes mutual interaction between said amplitude control means and said pulse width control means which causes the pulse width to increase by 40% responsive to a decrease in the amplitude of 25% followed by their return to their initial values.
Claim 14
Dependent Claim
34 words
A device according to claim 12 wherein said mutual interaction results in specific amplitude and pulse width values which is plotted would approximate the A-gamma-motor strength duration curve associated with the nerve being stimulated.
Claim 15
Dependent Claim
26 words
A device according to claim 13 wherein said pulse width increases in response to a decrease in amplitude until said pulse width reaches the A-delta-pain line.
Claim 16
Dependent Claim
63 words
A device according to claim 1 wherein said prescribed manner includes mutual interaction between said amplitude control means and said pulse width control means and has a modulation cycle of six seconds, said modulation cycle being the time of the rate modulation as well as the time involved in the mutual interaction between the pulse width control means and the amplitude control means.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-07-26 | 1992-01-25 | 1992-07-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-07-26 | 1996-01-25 | 1996-07-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-07-26 | 2000-01-25 | 2000-07-26 | $7700.00 | Window Closed / Lapsed |